ATRenew Inc. American Depositary Shares (every three of which representing two Class A ordinary shares) (RERE)
Fast GrowerFairStock Score: 66/100 — STEADY
Key Financials
| Current Price | $4.32 |
| Market Cap | $1.0B |
| P/E Ratio | 16.62 |
| ROE | 11.15% |
| Dividend Yield | 2.46% |
| Sector | Consumer Cyclical |
Strengths
- Conservative balance sheet with debt-to-equity of just 0.11, providing financial flexibility
- Revenue growth of 29.0% demonstrates strong top-line momentum
- Attractive 2.1% dividend yield providing steady income returns
Concerns
- Altman Z-Score of -0.1 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
ATRenew Inc. American Depositary Shares (every three of which representing two Class A ordinary shares) is a micro-cap consumer cyclical company valued at $1.0 billion. The business generates $21.0 billion in annual revenue with a 0.6% net margin. From a quality standpoint, ATRenew shows distressed Altman Z-Score of -0.1 warrants caution and modest 9% ROE. On valuation, the stock is reasonably priced at 23.4x earnings, with offers a 59% margin of safety vs Graham Number of $11. Growth dynamics show revenue growing at 29.0% and profit growth of 68.3%. The 2.1% dividend yield adds an income component for patient holders. Our composite FairStock Score of 66/100 reflects above-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
ATRenew's 29% revenue growth trajectory could accelerate as it captures additional market share in the consumer cyclical sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the consumer cyclical space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer